Transforming Hypertension Management in Nigeria
改变尼日利亚的高血压管理
基本信息
- 批准号:10587997
- 负责人:
- 金额:$ 69.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-15 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdoptionAdultAfrica South of the SaharaAfricanAlgorithmsAwarenessBloodBlood PressureCaliforniaCapitalCardiologyCardiovascular DiseasesCardiovascular systemCaringChronicCollaborationsCommunitiesCommunity Health AidesCountryDataDeveloping CountriesDiseaseDoseEffectivenessEffectiveness of InterventionsEnvironmentEpidemiologyEvaluationF FactorGoalsHIVHealthHealth StatusHealth care facilityHealth systemHeartHomeHome Blood Pressure MonitoringHybridsHypertensionIndividualInternationalInterruptionInterventionIntervention StudiesKidney DiseasesKnowledgeLow PrevalenceMaintenanceMedicalMedicineMethodologyMethodsModelingMonitorMorbidity - disease rateNational Heart, Lung, and Blood InstituteNigeriaNigerianOphthalmologyParticipantPathway interactionsPatient-Focused OutcomesPatientsPerformancePhysiciansPoliciesPrevalencePrimary Health CarePublic HealthQuality of CareReach Effectiveness Adoption Implementation and MaintenanceReportingResearchResearch DesignRiskRisk FactorsSamplingSeriesSocietiesStrategic visionStructureSystemTarget PopulationsTestingTimeTitrationsTranslatingTranslationsbaseblood pressure controlburden of illnessclinical practicecostdata modelingdesigneffectiveness evaluationeffectiveness studyevidence baseexperiencefollow-uphigh riskhypertension controlhypertension treatmentimplementation barriersimplementation evaluationimplementation outcomesimplementation scienceimplementation strategyimprovedlow and middle-income countriesmodifiable riskmortalitymultidisciplinarynovel strategiespatient advocacy grouppatient orientedprematurepressureprogramspublic health relevancerandomized trialscale upsocietal costssystematic reviewtreatment as usualtreatment guidelines
项目摘要
PROJECT
ABSTRACT
Elevated
and
based
very
blood pressure (BP) is a leading modifiable risk factor f or global cardiovascular disease morbidity
mortality. In Nigeria, the most populou country in sub-Saharan Africa, the prevalence of hypertension
on a BP threshold >140/90 mmHg in adults (>40 years) has been estimated to be 45%. 1 Despite this
high burden, hypertension awareness (14-30%), treatment (<20%), and control (9%) rates are very low in
s
Nigeria. 2 A 2018 systematic review of 119 trials (n=55,641 participants) evaluating implementation strategies
for improving BP control demonstrated that multi-level team-based care with non-physician health worker
titration of BP lowering medicines was the most effective approach for lowering systolic BP (-7.1 mmHg [95%
CI: -8.9, -5.2], 10 trials).3 The most effective patient-centered interventions for lowering systolic BP were health
coaching (-3.9 mmHg [95% CI: -5.4, -2.3], 38 trials) and home BP monitoring (-2.7 mmHg [95% CI: -3.6, -1.7],
26 trials). Importantly, <20% of the studies in this systematic review were from low- and middle-income
countries, and none were from sub-Saharan Africa.
Translating these findings into routine clinical practice requires systems to track patients, performance
review, algorithms, physicians to cede control to non-physicians, and non-physicians to cede control to and to
support patients, much like how HIV care is structured throughout sub-Saharan Africa. Our pilot data (n=60)
from Abuja, Nigeria already demonstrate feasibility and short-term efficacy in lowering systolic BP at 1 month
with community health worker-led care (-10.5 mmHg [95% CI: -15.4, -5.5]) and home BP monitoring (-7.3
mmHg [95% CI: -11.7, -2.8]) compared with usual care.
In this proposal, we will utilize implementation science methodologies including the Reach Effectiveness
Adoption Implementation Maintenance (RE-AIM) framework to adapt, implement, and evaluate an evidence-
based, multi-level intervention that includes: (1) system-level hypertension program adapted from Kaiser
Permanente Northern California's model in public, primary health care facilities in Federal Capital Territory
[Abuja], Nigeria, and (2) patient-level health coaching with home BP monitoring in a sample of high-risk
patients with uncontrolled hypertension. We will study the effectiveness and implementation of these adapted
interventions through an interrupted time series design on hypertension treatment and control rates, as well as
patient-centered outcomes. We
as
will also evaluate the implementation outcomes using the RE-AIM framework,
well as acceptability and cost, at system and patient levels for both interventions.This proposal directly addresses critical challenge #11 of the NHLBI's Strategic Vision: “Multidisciplinary,
multinational partnerships are needed to develop effective and sustainable strategies for combating chronic
HLBS disorders in developing nations, which take into account the highly variable local epidemiology of HLBS
disorders, the need for novel approaches to reducing disease burden, and the challenges of implementation.”4
工程
摘要
高架
和
基于
非常
血压(BP)是全球心血管疾病发病率的主要可修改危险因素
死亡率。在撒哈拉以南非洲人口最多的国家尼日利亚,高血压的患病率
在血压阈值>;140/90毫米汞柱上,成年人(>;40岁)估计为45%。尽管如此,1
高负担、高血压知晓率(14-30%)、治疗(20%)和控制率(9%)在
S
尼日利亚。2 2018年对119项试验(n=55641名参与者)进行的系统审查,评估执行战略
为了改善血压控制,展示了与非医生卫生工作者进行多层次团队护理
滴定降血压药物是降低收缩压(-7.1 mm Hg[95%])的最有效方法
CI:-8.9,-5.2],10项试验)。3以患者为中心的降低收缩压最有效的干预措施是健康
教练(-3.9毫米汞柱[95%可信区间:-5.4,-2.3],38次试验)和家庭血压监测(-2.7毫米汞[95%可信区间:-3.6,-1.7],
26次试验)。重要的是,在这项系统性综述中,有20%的研究来自中低收入人群。
没有一个人来自撒哈拉以南非洲。
将这些发现转化为常规的临床实践需要系统来跟踪患者、表现
审查、算法、医生将控制权让给非医生,以及非医生将控制权让给和让给
支持患者,很像整个撒哈拉以南非洲地区艾滋病毒护理的结构。我们的试点数据(n=60)
来自阿布贾的尼日利亚已经证明了在1个月时降低收缩压的可行性和短期疗效
社区卫生工作者主导的护理(-10.5毫米汞柱[95%可信区间:-15.4,-5.5])和家庭血压监测(-7.3
毫米汞柱[95%CI:-11.7,-2.8])。
在这项提案中,我们将利用实施科学方法,包括REACH有效性
采用实施维护(RE-AIM)框架以适应、实施和评估证据-
基于多层次的干预措施,包括:(1)改编自Kaiser的系统级高血压计划
北加州联邦首都地区公共初级卫生保健设施的永久模式
[阿布贾],尼日利亚,和(2)患者层面的健康指导,在高危人群样本中进行家庭血压监测
患有失控高血压的患者。我们会研究这些改编措施的成效和实施情况。
通过中断的时间序列设计对高血压治疗和控制率以及
以患者为中心的结果。我们
AS
还将使用RE-AIM框架评估执行成果,
以及系统和患者层面的可接受性和成本。这项建议直接解决了NHLBI战略愿景的关键挑战#11:“多学科,
需要多国伙伴关系来制定有效和可持续的防治慢性疾病的战略。
发展中国家的HLBS疾病,这考虑到HLBS的高度可变的当地流行病学
疾病、减少疾病负担的新方法的必要性以及实施的挑战。“4
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark D Huffman其他文献
Blood biomarkers of trans-fatty acid intake among Nigerian adults in the Federal Capital Territory: a cross-sectional study
尼日利亚联邦首都区成年人反式脂肪酸摄入的血液生物标志物:一项横断面研究
- DOI:
10.1016/j.ajcnut.2024.10.019 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:6.900
- 作者:
Matti Marklund;Soji Billyrose;Ikechukwu A Orji;Mercy U Ikechukwu-Orji;Clementina Okoro;Chijioke Obagha;Guhan Iyer;Erica L Jamro;Adedayo Ojo;William S Harris;Jason HY Wu;Lisa R Hirschhorn;Linda Van Horn;Mark D Huffman;Dike B Ojji - 通讯作者:
Dike B Ojji
Implementation of the Extension for Community Healthcare Outcomes Model for Hypertension Education of Frontline Health Care Workers in the Federal Capital Territory, Nigeria: Explanatory Sequential Mixed Methods Evaluation
尼日利亚联邦首都地区基层医护人员高血压教育的社区医疗保健结果模型扩展的实施:解释性顺序混合方法评估
- DOI:
10.2196/66351 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:6.000
- 作者:
Abigail S Baldridge;Adaora Odukwe;Olabisi Dabiri;L Nneka Mobisson;Maria Moosa Munnee;Ayoposi Ogboye;Dorothy Naa Korkoi Aryee;Rodrick Mwale;Jonas Akpakli;Ikechukwu A Orji;Rosemary C B Okoli;Nanna R Ripiye;Dike B Ojji;Mark D Huffman;Namratha R Kandula;Lisa R Hirschhorn - 通讯作者:
Lisa R Hirschhorn
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data
阿司匹林用于心血管疾病一级预防的全球流行率:全国代表性个人数据的横断面研究
- DOI:
10.5334/gh.1323 - 发表时间:
2024 - 期刊:
- 影响因子:3.7
- 作者:
Sang Gune K. Yoo;Grace S Chung;S. Bahendeka;A. Sibai;Albertino Damasceno;F. Farzadfar;Peter Rohloff;Corine Houehanou;Bolormaa Norov;K. Karki;M. Azangou;M. Marcus;Krishna K Aryal;Luisa C. C. Brant;M. Theilmann;R. Cífková;Nuno Lunet;M. Gurung;J. K. Mwangi;Joao Martins;Rosa Haghshenas;L. Sturua;Sebastian Vollmer;Till Bärnighausen;R. Atun;Jeremy B. Sussman;Kavita Singh;S. Moghaddam;D. Guwatudde;P. Geldsetzer;J. Manne;Mark D Huffman;Justine I. Davies;David Flood - 通讯作者:
David Flood
The place of polypill in secondary prevention of stroke.
复方丸在脑卒中二级预防中的地位。
- DOI:
10.1016/s2214-109x(23)00407-2 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Dike B Ojji;Mark D Huffman - 通讯作者:
Mark D Huffman
Mark D Huffman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark D Huffman', 18)}}的其他基金
Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program
评估尼日利亚国家减钠计划的实施和扩大规模
- 批准号:
9974384 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program
评估尼日利亚国家减钠计划的实施和扩大规模
- 批准号:
10260513 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program
评估尼日利亚国家减钠计划的实施和扩大规模
- 批准号:
10514995 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Transforming Hypertension Management in Nigeria
改变尼日利亚的高血压管理
- 批准号:
10698047 - 财政年份:2019
- 资助金额:
$ 69.13万 - 项目类别:
Transforming Hypertension Management in Nigeria
改变尼日利亚的高血压管理
- 批准号:
10162412 - 财政年份:2019
- 资助金额:
$ 69.13万 - 项目类别:
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)
喀拉拉邦急性冠状动脉综合征质量改善 (ACS QUIK)
- 批准号:
8843572 - 财政年份:2014
- 资助金额:
$ 69.13万 - 项目类别:
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)
喀拉拉邦急性冠状动脉综合征质量改善 (ACS QUIK)
- 批准号:
9099883 - 财政年份:2014
- 资助金额:
$ 69.13万 - 项目类别:
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)
喀拉拉邦急性冠状动脉综合征质量改善 (ACS QUIK)
- 批准号:
8471765 - 财政年份:2012
- 资助金额:
$ 69.13万 - 项目类别:
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)
喀拉拉邦急性冠状动脉综合征质量改善 (ACS QUIK)
- 批准号:
8242535 - 财政年份:2012
- 资助金额:
$ 69.13万 - 项目类别:
相似海外基金
How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
- 批准号:
2315783 - 财政年份:2023
- 资助金额:
$ 69.13万 - 项目类别:
Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
- 批准号:
2719534 - 财政年份:2022
- 资助金额:
$ 69.13万 - 项目类别:
Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
- 批准号:
20K01113 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633211 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2436895 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633207 - 财政年份:2020
- 资助金额:
$ 69.13万 - 项目类别:
Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
- 批准号:
19K01745 - 财政年份:2019
- 资助金额:
$ 69.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
- 批准号:
426559561 - 财政年份:2019
- 资助金额:
$ 69.13万 - 项目类别:
Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
- 批准号:
2236701 - 财政年份:2019
- 资助金额:
$ 69.13万 - 项目类别:
Studentship
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
- 批准号:
415543446 - 财政年份:2019
- 资助金额:
$ 69.13万 - 项目类别:
Research Fellowships